Literature DB >> 22438539

Evaluation of pneumonia virus of mice as a possible human pathogen.

Linda G Brock1, Ruth A Karron, Christine D Krempl, Peter L Collins, Ursula J Buchholz.   

Abstract

Pneumonia virus of mice (PVM), a relative of human respiratory syncytial virus (RSV), causes respiratory disease in mice. There is serologic evidence suggesting widespread exposure of humans to PVM. To investigate replication in primates, African green monkeys (AGM) and rhesus macaques (n = 4) were inoculated with PVM by the respiratory route. Virus was shed intermittently at low levels by a subset of animals, suggesting poor permissiveness. PVM efficiently replicated in cultured human cells and inhibited the type I interferon (IFN) response in these cells. This suggests that poor replication in nonhuman primates was not due to a general nonpermissiveness of primate cells or poor control of the IFN response. Seroprevalence in humans was examined by screening sera from 30 adults and 17 young children for PVM-neutralizing activity. Sera from a single child (6%) and 40% of adults had low neutralizing activity against PVM, which could be consistent with increasing incidence of exposure following early childhood. There was no cross-reaction of human or AGM sera between RSV and PVM and no cross-protection in the mouse model. In native Western blots, human sera reacted with RSV but not PVM proteins under conditions in which AGM immune sera reacted strongly. Serum reactivity was further evaluated by flow cytometry using unfixed Vero cells infected with PVM or RSV expressing green fluorescent protein (GFP) as a measure of viral gene expression. The reactivity of human sera against RSV-infected cells correlated with GFP expression, whereas reactivity against PVM-infected cells was low and uncorrelated with GFP expression. Thus, PVM specificity was not evident. Our results indicate that the PVM-neutralizing activity of human sera is not due to RSV- or PVM-specific antibodies but may be due to low-affinity, polyreactive natural antibodies of the IgG subclass. The absence of PVM-specific antibodies and restriction in nonhuman primates makes PVM unlikely to be a human pathogen.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22438539      PMCID: PMC3347304          DOI: 10.1128/JVI.00163-12

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  70 in total

1.  Identification of a novel coronavirus in patients with severe acute respiratory syndrome.

Authors:  Christian Drosten; Stephan Günther; Wolfgang Preiser; Sylvie van der Werf; Hans-Reinhard Brodt; Stephan Becker; Holger Rabenau; Marcus Panning; Larissa Kolesnikova; Ron A M Fouchier; Annemarie Berger; Ana-Maria Burguière; Jindrich Cinatl; Markus Eickmann; Nicolas Escriou; Klaus Grywna; Stefanie Kramme; Jean-Claude Manuguerra; Stefanie Müller; Volker Rickerts; Martin Stürmer; Simon Vieth; Hans-Dieter Klenk; Albert D M E Osterhaus; Herbert Schmitz; Hans Wilhelm Doerr
Journal:  N Engl J Med       Date:  2003-04-10       Impact factor: 91.245

2.  Production of infectious human respiratory syncytial virus from cloned cDNA confirms an essential role for the transcription elongation factor from the 5' proximal open reading frame of the M2 mRNA in gene expression and provides a capability for vaccine development.

Authors:  P L Collins; M G Hill; E Camargo; H Grosfeld; R M Chanock; B R Murphy
Journal:  Proc Natl Acad Sci U S A       Date:  1995-12-05       Impact factor: 11.205

3.  Diagnosis of murine infections in relation to test methods employed.

Authors:  V Kraft; B Meyer
Journal:  Lab Anim Sci       Date:  1986-06

4.  Genome sequence of the non-pathogenic strain 15 of pneumonia virus of mice and comparison with the genome of the pathogenic strain J3666.

Authors:  L C Thorpe; A J Easton
Journal:  J Gen Virol       Date:  2005-01       Impact factor: 3.891

5.  Genomic analysis of a pneumovirus isolated from dogs with acute respiratory disease.

Authors:  Randall Renshaw; Melissa Laverack; Nancy Zylich; Amy Glaser; Edward Dubovi
Journal:  Vet Microbiol       Date:  2011-01-15       Impact factor: 3.293

6.  Complete sequence of the RNA genome of pneumonia virus of mice (PVM).

Authors:  Christine D Krempl; Elaine W Lamirande; Peter L Collins
Journal:  Virus Genes       Date:  2005-03       Impact factor: 2.332

7.  Pathogenesis of pneumovirus infections in mice: detection of pneumonia virus of mice and human respiratory syncytial virus mRNA in lungs of infected mice by in situ hybridization.

Authors:  P M Cook; R P Eglin; A J Easton
Journal:  J Gen Virol       Date:  1998-10       Impact factor: 3.891

8.  New isolates of pneumonia virus of mice (PVM) from Japanese rat colonies and their characterization.

Authors:  H Miyata; M Kishikawa; H Kondo; C Kai; Y Watanabe; K Ohsawa; H Sato
Journal:  Exp Anim       Date:  1995-04

9.  Role of complement in neutralization of respiratory syncytial virus.

Authors:  Sandra M Yoder; Yuwei Zhu; Mine R Ikizler; Peter F Wright
Journal:  J Med Virol       Date:  2004-04       Impact factor: 2.327

10.  A newly discovered human pneumovirus isolated from young children with respiratory tract disease.

Authors:  B G van den Hoogen; J C de Jong; J Groen; T Kuiken; R de Groot; R A Fouchier; A D Osterhaus
Journal:  Nat Med       Date:  2001-06       Impact factor: 53.440

View more
  5 in total

1.  Murine Pneumonia Virus Expressing the Fusion Glycoprotein of Human Respiratory Syncytial Virus from an Added Gene Is Highly Attenuated and Immunogenic in Rhesus Macaques.

Authors:  Linda G Brock; Xiang Liu; Bo Liang; Matthias Lingemann; Xueqiao Liu; Richard Herbert; Ashley D Hackenberg; Ursula J Buchholz; Peter L Collins; Shirin Munir
Journal:  J Virol       Date:  2018-08-16       Impact factor: 5.103

2.  Animal model of respiratory syncytial virus: CD8+ T cells cause a cytokine storm that is chemically tractable by sphingosine-1-phosphate 1 receptor agonist therapy.

Authors:  Kevin B Walsh; John R Teijaro; Linda G Brock; Daniel M Fremgen; Peter L Collins; Hugh Rosen; Michael B A Oldstone
Journal:  J Virol       Date:  2014-03-26       Impact factor: 5.103

3.  Respiratory syncytial virus: virology, reverse genetics, and pathogenesis of disease.

Authors:  Peter L Collins; Rachel Fearns; Barney S Graham
Journal:  Curr Top Microbiol Immunol       Date:  2013       Impact factor: 4.291

4.  Extraribosomal l13a is a specific innate immune factor for antiviral defense.

Authors:  Barsanjit Mazumder; Darshana Poddar; Abhijit Basu; Ravinder Kour; Valentina Verbovetskaya; Sailen Barik
Journal:  J Virol       Date:  2014-06-04       Impact factor: 5.103

Review 5.  The Pneumonia Virus of Mice (PVM) model of acute respiratory infection.

Authors:  Kimberly D Dyer; Katia E Garcia-Crespo; Stephanie Glineur; Joseph B Domachowske; Helene F Rosenberg
Journal:  Viruses       Date:  2012-12       Impact factor: 5.048

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.